"Before you vaccinate millions of healthy 20 year olds, and give Pfizer billions, we usually run trials to ensure the benefit exists," epidemiologist says, objecting to lack of evidence for bivalent booster mandates.
"Our estimate suggests an expected net harm from boosters in this young adult age group, whereby the negative outcomes of all severe adverse events and hospitalizations may on average outweigh the expected benefits in terms of Covid-19 hospitalizations averted," say study authors from Oxford, Harvard, and Johns Hopkins.
There is no longer evidence that suggests anyone should get the COVID-19 vaccines, a British mathematician said as the UK government rolls out another booster campaign ahead of the winter season.
FDA expected to authorize new COVID-19 booster shots this week. The booster shots will be released months before trials on humans are completed, according to a new report.